Physician profile
Robert T Love
NPI 1497725493
$1,444.16
in general payments reported to CMS, 2019-2025
12 companies · $673 in 2025
The $673 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $90.31 · 2021: $158 · 2022: $97.71 · 2024: $33.63 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $526.52 | 2025 | |
| Kci USA, INC. | $258.98 | 2019-2022 | |
| Allergan, INC. | $216.92 | 2019-2021 | |
| Solventum Corporation | $120.47 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Mentor Worldwide LLC | $107.61 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $107.39 | 2019 | |
| Innovation Technologies INC | $33.63 | 2024 | Irrisept |
| Somavac Medical Solutions, INC. | $16.74 | 2021 | |
| Apyx Medical Corporation | $15.01 | 2019 | |
| Acell, INC. | $15.00 | 2020 | |
| Medline Industries LP | $14.76 | 2019 | |
| Organogenesis INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Love listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.